#Djokovic bets on a COVID cure as he quests for #Tennis history


The Serbian superstar, who became a focus of the global vaccine debate over his failed attempt to enter Australia without being inoculated, holds a majority stake in a Danish biotech firm aiming to develop a treatment to counter COVID-19, the company’s CEO told Reuters.

QuantBioRes boss Ivan Loncarevic, who described himself as an entrepreneur, said the tennis player’s acquisition of the 80% stake was made in June 2020 but declined to say how much it was.

The company is developing a peptide, which inhibits the coronavirus from infecting the human cell, expects to launch clinical trials in Britain this summer, according to Loncarevic, who stressed the firm was working on a treatment, not a vaccine.

The CEO said the company had about a dozen researchers working in Denmark, Australia and Slovenia.

The CEO said the company had about a dozen researchers working in Denmark, Australia and Slovenia. According to the Danish company register, Djokovic and his wife Jelena own 40.8% and 39.2% of the company, respectively.

Read more at: Djokovic bets on a COVID cure as he quests for tennis history | Reuters



Categories: Tennis

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: